Esperion Therapeutics, Inc. (ESPR) NASDAQ

1.00

+0.0156(+1.58%)

Updated at July 01 04:00PM

Currency In USD

Valuation

Market Cap411.8M
Enterprise Value564.64M
P/E Ratio-1.32
PEG Ratio0.01
Price/Sales Ratio0.79
Price/Book Ratio-0.48
Enterprise/Revenue1.5
Enterprise/EBITDA-4.39

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.59
Operating Margin-0.15

Management Effectiveness

Return On Assets-0.47
Return On Equity0.4

Income Statement

Revenue332.31M
Revenue/Share1.32
Gross Profit263.71M
EBITDA7.57M
Net Income-51.75M
Diluted EPS-0.28

Balance Sheet

Total Cash114.63M
Total Cash/Share0.58
Total Debt297.78M
Total Debt/Equity-0.7
Current Ratio1.18
Book Value Per Share-2.17

Price History

52-Week Change-55.77
52-Week High3.94
52-Week Low0.69
Moving Average 50 Days0.97
Moving Average 200 Days1.73

Statistics

Average Volume5.16M
Shares Outstanding198.2M
% Held by Institutions57.76

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A